Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-044544

General Counsel sold 4,087 shares at $2.25 ($9,196)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Sale : show line 1 in the form −4,087 $2.25 $9,196 541,013 D
Open-market sales · 4,087 sh · avg $2.25 · $9,196
Loading xslF345X06/form4.xml…